Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

This is a pilot study to generate hypotheses about the urodynamic effects of UK-369,003 in men with lower urinary tract symptoms.

Phase 2

Pfizer